发明名称 |
Method for treating chronic lymphocytic leukemia (CC) |
摘要 |
The present invention relates generally to the treatment of PML by infusion of activated and expanded autologous lymphocytes. |
申请公布号 |
US9161971(B2) |
申请公布日期 |
2015.10.20 |
申请号 |
US201213537330 |
申请日期 |
2012.06.29 |
申请人 |
The Trustees of the University of Pennsylvania |
发明人 |
June Carl H.;Levine Bruce;Chew Anne;Schuster Stephen J. |
分类号 |
A61K35/12;A61K39/00;C12N5/00;C12N5/0783 |
主分类号 |
A61K35/12 |
代理机构 |
Saul Ewing LLP |
代理人 |
Saul Ewing LLP ;Doyle Kathryn;Morgan Kelly J. |
主权项 |
1. A method for treating Chronic Lymphocytic Leukemia (CLL) comprising administering to a patient with CLL a single dose comprising a population of about 5×109 to about 2×1010 autologous T cells activated and expanded according to a method comprising,
(a) activating a population of T cells in vitro with an agent which stimulates a TCR/CD3 complex-associated signal in the T cells, wherein the agent is attached on a surface; and (b) stimulating a CD28 accessory molecule on the surface of the T cells in vitro with a ligand that binds the CD28 accessory molecule on the surface of the T cells, wherein the ligand is attached on the same surface as the agent; andwherein the activating and stimulating steps thereby induce proliferation of the T cells such that T cell counts are increased in the CLL patient at least one month after administration. |
地址 |
Philadelphia PA US |